These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1114128)

  • 21. [Immunological and protein studies in proliferative hemocytopathies].
    Szmigiel Z; Gaertner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(4):388-93. PubMed ID: 4168274
    [No Abstract]   [Full Text] [Related]  

  • 22. Orosomucoid content of pleural and peritoneal effusions.
    Rudman D; Chawla RK; Del Rio AE; Hollins BM; Hall EC; Conn JM
    J Clin Invest; 1974 Jul; 54(1):147-55. PubMed ID: 4209434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The interrelation of normal natural killers and hemopoietic cells and in malignant diseases of the blood system].
    Glazanova TV
    Vopr Onkol; 1989; 35(9):1027-31. PubMed ID: 2683379
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on the abnormalities of serum alpha 1-acid glycoprotein in alcoholic patients].
    Kohgo Y; Matsumoto S; Nishisato T; Kato J; Fukushima M; Akiyama M; Niitsu Y; Urushizaki I; Nakamura K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2008-13. PubMed ID: 3795569
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new two-stage plan for isolating human alpha1-acidic glycoprotein (orosomucoid). Orosomucoid interacts with ethidium bromide].
    Trubetskaia OE; Muranova TA; Rezikova OI; Afanas'eva GV; Reznikov KIu
    Bioorg Khim; 1994 Dec; 20(12):1297-309. PubMed ID: 7695648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microheterogeneity of orosomucoid in pathological conditions.
    Hansen JE; Bøg-Hansen TC; Pedersen B; Neland K
    Electrophoresis; 1989; 10(8-9):574-8. PubMed ID: 2806205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hematopoietic proliferative syndromes with a semi-synthetic podophyllin derivative].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Polubiec A; Kolakowska-Polubiec K; Domańska B; Kolakowski L
    Acta Haematol Pol; 1973; 4(2):123-7. PubMed ID: 4740783
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum orosomucoid volume--quantitative methods and serum levels in various diseases].
    Ishigami S; Koda T; Tanabe S; Furuo T; Ito F
    Rinsho Byori; 1971 Aug; 19():Suppl:143-4. PubMed ID: 4110108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Modern treatment of leukemia and hematopoietic stem cell transplantation].
    Pejin D; Stefanović N; Belić A; Popović S; Spasojević J; Uzurov V; Savić I; Savić A
    Med Pregl; 1997; 50(11-12):473-9. PubMed ID: 9471506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of therapy on the haptaglobin level in leukemic patients].
    Turowska B; Gurda M
    Przegl Lek; 1967; 23(4):381-2. PubMed ID: 5232813
    [No Abstract]   [Full Text] [Related]  

  • 31. The mechanism of myelopoiesis inhibition in childhood acute leukemia.
    Vladimirskaya EB
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):537-41. PubMed ID: 2414182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients.
    Ganz PA; Shell WE; Tökés ZA
    J Natl Cancer Inst; 1983 Jul; 71(1):25-30. PubMed ID: 6575206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of chemotherapy of malignant diseases of the hematopoietic organs].
    Ducach G
    Rev Med Chil; 1970 May; 98(5):309-21. PubMed ID: 5478171
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of dexamethasone on Flt3 receptor expression and proliferation induced by recombinant human Flt3 ligand in malignant hematopoietic cells.
    Xu ZX; Xu Y; Zhu JK; Li CX; Li Y; Zhang XG
    Acta Pharmacol Sin; 2001 Jun; 22(6):534-40. PubMed ID: 11747761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Free nucleotides of erythrocytes in proliferative diseases of the hemopoietic system].
    Zdebska E; Maj S; Daszyński J; Radziszewski J
    Acta Haematol Pol; 1972; 3(2):119-24. PubMed ID: 4144097
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems of the diagnosis and treatment of infection in proliferative diseases of the hematopoietic system].
    Sułek K
    Pol Tyg Lek; 1982 Sep; 37(36):1077-9. PubMed ID: 7170262
    [No Abstract]   [Full Text] [Related]  

  • 37. Orosomucoid 1 phenotyping from human urine by isoelectric focusing.
    Harada A; Umetsu K; Yuasa I; Ikeda N; Suzuki T
    J Forensic Sci; 1990 Sep; 35(5):1191-5. PubMed ID: 2230692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endogenous regulators of hematopoiesis and their role in the therapy of leukemias].
    Svirnovskiĭ AI
    Ter Arkh; 1988; 60(5):152-6. PubMed ID: 3051485
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of the treatment of acute leukemia in relation to the sensitivity of leukemia cells to cytostatic drugs].
    Klimenko VI; Romanova AF; Zverkova AS; Evtukh VP
    Vrach Delo; 1988 Jun; (6):86-8. PubMed ID: 3420922
    [No Abstract]   [Full Text] [Related]  

  • 40. Variation of plasma fibronectin levels in leukemia patients.
    Kageyama T; Ohyabu H; Ohshiba S
    Bull Osaka Med Coll; 1989 Nov; 35(1-2):71-6. PubMed ID: 2486245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.